Article
Botulinum shows promise for added urologic indications
Jena, Germany-Botulinum toxin has shown promise as a potential therapy for chronic pelvic pain and lower urinary tract dysfunction. In a German study, injection of botulinum toxin type A into the urethral sphincter muscle led to improvement in muscle tone, pain, and urodynamic parameters in patients enrolled.
Related Videos
Yahir A. Santiago-Lastra, MD, discusses barriers to vaginal estrogen access
Expert discusses genitourinary syndrome of menopause guidelines
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Urology CNP discusses sensitivity in communication, physical exam
Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
Urologist discusses drug cost savings, price transparency
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
Raymond Xu, MD, discusses Cost Plus Drugs and urogynecologic medications
Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause
Related Content
April 28th 2025
